Literature Highlights - June 2022

SLE, prolonged complete remission, off therapy, mortality; race, ethnicity, end-organ, CLUES, risk, multiorgan; belimumab, organ damage, LN; B-Lymphocytes; immune system diseases; lupus Erythematosus, Systemic; systematic lupus erythematosus, autoimmunity, biologic therapies, anifrolumab, population pharmacokinetics, exposure–response, clearance, efficacy, safety; frailty, mortality; drug–drug interactions, mycophenolic acid, pharmacokinetics, voclosporin

Read more…

Literature Highlights - May 2022

SLE, prolonged complete remission, off therapy, mortality; race, ethnicity, end-organ, CLUES, risk, multiorgan; belimumab, organ damage, LN; B-Lymphocytes; immune system diseases; lupus Erythematosus, Systemic; systematic lupus erythematosus, autoimmunity, biologic therapies, anifrolumab, population pharmacokinetics, exposure–response, clearance, efficacy, safety; frailty, mortality; drug–drug interactions, mycophenolic acid, pharmacokinetics, voclosporin

Read more…

Literature Highlights - April 2022

SLE, biologics, rituximab; biological therapy; systemic lupus erythematosus; systemic; therapeutics, interferon signature gene, lupus nephritis, podocyte injury type I interferon, anifrolumab, interferon, pharmacodynamics, pharmacokinetics, remission, lupus low disease activity state, health related quality of life, treat-to-target

Read more…

Literature Highlights - March 2022

hydroxychloroquine; systemic lupus erythematosus; patient-reported outcomes; healthcare resource utilisation; health-related quality of life; qualitative; interferon gene; biomarker; autoimmune rheumatic disease; antinuclear antibodies; anti-citrullinated protein antibodies; glucocorticoids; meta-analysis; cutaneous; methotrexate; chloroquine; belimumab; fertility abnormalities; gonadotropin-releasing hormone; myocardial infarction; systemic lupus international collaborating clinics frailty index; prednisolone; thrombocytopenia

Read more…

Literature Highlights - February 2022

hydroxychloroquine; systemic lupus erythematosus; patient-reported outcomes; healthcare resource utilisation; health-related quality of life; qualitative; interferon gene; biomarker; autoimmune rheumatic disease; antinuclear antibodies; anti-citrullinated protein antibodies; glucocorticoids; meta-analysis; cutaneous; methotrexate; chloroquine; belimumab; fertility abnormalities; gonadotropin-releasing hormone; myocardial infarction; systemic lupus international collaborating clinics frailty index; prednisolone; thrombocytopenia

Read more…